Silence Therapeutics – The GOLDen future of RNAi Research
Mark Rothera, President and CEO of Silence Therapeutics discusses RNAi research and how the company is applying its mRNAi GOLD™ platform to precisely ...
3315 articles
Mark Rothera, President and CEO of Silence Therapeutics discusses RNAi research and how the company is applying its mRNAi GOLD™ platform to precisely ...
Devon Christie, MD, is the Medical and Therapeutic Services Director with Numinus Wellness Inc., a Canadian-based company at the forefront of advancing ...
Lisa Anderson, CEO, President and co-founder of Paragonix Technologies, Inc., a company delivering a new standard in organ preservation and transport, d...
Carla Mack, Global Head of Professional Affairs at Alcon discusses the company's latest innovation, TOTAL30®, the first-and-only monthly replacement, w...
August is Spinal Muscular Atrophy (SMA) Awareness Month, and this year (2021) also marks the first anniversary of the FDA approval of Evrysdi (risdiplan...
Michael Frank, CEO and Chairman of Revive Therapeutics discusses the Phase 3 trial of Bucillamine, a well known prescribed anti-inflammatory drug in Jap...
Erik Rifkin, PhD, co-founders of the Center for Interpreting Health Benefits and Risk discuss their new book "Understanding COVID-19 Risks: An Image is ...
Jasmin Makar, MD, a pediatrician with Stanford Children's Health, discusses ways kids can stay safe as they go back to school, the importance of s...
Vincent Myers, President and co-founding member of DIGroup Architecture, an award winning design firm in New Brunswick, New Jersey discusses why senior ...
Michael Forbes, Pediatric & Adolescent Intensive Care Specialist and the Director of PICU Clinical Research & Outcomes Analysis at Akron Children’s Ho...